CoChat

6. Glycemic Targets

Open access
American Diabetes Association · 2015 · Diabetes Care

The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.

Abstract

Two primary techniques are available for health providers and patients to assess the effectiveness of the management plan on glycemic control: patient self-monitoring of blood glucose (SMBG) or interstitial glucose and A1C.Continuous glucose monitoring (CGM) may be a useful adjunct to SMBG in selected patients.Recommendations c When prescribed as part of a broader educational context, SMBG results may help guide treatment decisions and/or self-management for patients using less frequent insulin injections B or noninsulin therapies.E c When prescribing SMBG, ensure that patients receive ongoing instruction and regular evaluation of SMBG technique, SMBG results, and their ability to use SMBG data to adjust therapy.E c Patients on multiple-dose insulin or insulin pump therapy should perform SMBGprior to meals and snacks, occasionally postprandially, at bedtime, prior to exercise, when they suspect low blood glucose, after treating low blood glucose until they are normoglycemic, and prior to critical tasks such as driving.B c When used properly, CGM in conjunction with intensive insulin regimens is a useful tool to lower A1C in selected adults (aged $25 years) with type 1 diabetes.A c Although the evidence for A1C lowering is less strong in children, teens, and younger adults, CGM may be helpful in these groups.Success correlates with adherence to ongoing use of the device.B c CGM may be a supplemental tool to SMBG in those with hypoglycemia unawareness and/or frequent hypoglycemic episodes.C c Given variable adherence to CGM, assess individual readiness for continuing use of CGM prior to prescribing.E c When prescribing CGM, robust diabetes education, training, and support are required for optimal CGM implementation and ongoing use.E Suggested citation: American Diabetes

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/dc15-s009

Cites

58 of 58 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 58 references

Cited by

See all 205

Metadata

Authors
American Diabetes Association
Corresponding author
American Diabetes Association
Venue
Diabetes Care
Published
2014-12-17
Volume
38
Issue
Supplement_1
Pages
S33-S40
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W4241059420
Cited by
205
References
58
Citations by year
2025: 2 · 2024: 4 · 2023: 7 · 2022: 9 · 2021: 8 · 2020: 5 · 2019: 22 · 2018: 15 · 2017: 37 · 2016: 59 · 2015: 34 · 2014: 1
FWCI
35.10
Type
journal article
Language
en
Open access
Locations
  • Diabetes Care (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
glycemic control, glycemic targets, self-monitoring of blood glucose, continuous glucose monitoring, HbA1c, type 1 diabetes, hypoglycemia, hypoglycemia unawareness, diabetes self-management education, insulin therapy, device adherence
MeSH terms
Blood Glucose, Diabetes Mellitus, Glycated Hemoglobin, Humans, Hypoglycemic Agents, Patient Care Planning, Blood Glucose Self-Monitoring, Monitoring, Ambulatory

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: 6. Glycemic Targets. https://app.cochat.ai/papers/10.2337/dc15-s009
The paper
American Diabetes Association. (2015). 6. Glycemic Targets. Diabetes Care. https://doi.org/10.2337/dc15-s009

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.